NeOnc Technologies Holdings, Inc. - Common Stock (NQ:NTHI)

8.638 +0.368 (+4.45%)

Streaming Delayed Price Updated: 12:55 PM EST, Jan 2, 2026 Add to My Watchlist

Price and Volume

Volume	21,508
Open	8.470
Bid (Size)	8.350 (100)
Ask (Size)	8.790 (100)
Prev. Close	8.270
Today's Range	8.390 - 8.960
52wk Range	3.200 - 25.00
Shares Outstanding	19,474,303
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

New to The Street Show #710 Airs Tonight at 6:30 PM EST on Bloomberg Television

December 27, 2025

Via ACCESS Newswire

New to The Street Broadcasts Nationwide Tonight on Bloomberg Television Featuring NeOnc ($NTHI), Metaterra Holdings Inc., CISO Global ($CISO), and NRx Pharmaceuticals ($NRXP)

December 20, 2025

Via ACCESS Newswire

Performance

YTD	N/A	N/A
1 Month	-0.9%	-0.9%
3 Month	-24.2%	-24.2%
6 Month	+48.2%	+48.2%
1 Year	-28.7%	-28.7%

More News

NeOnc Technologies Reports Updated Clinical Results

December 15, 2025

From NeOnc Technologies Holdings, Inc.

Via GlobeNewswire

NeOnc Technologies (Nasdaq: NTHI) Announces AI-Driven Findings Showing Ultrasound Enhances the Potency of an Already Effective NEO100 in Treating Primary and Metastatic Brain Tumors

December 01, 2025

From NeOnc Technologies Holdings, Inc.

Via GlobeNewswire

NeOnc Technologies Holdings Reports Third Quarter 2025 Results and Provides Operational Update

November 14, 2025

From NeOnc Technologies Holdings, Inc.

Via GlobeNewswire

NeOnc Technologies Completes Enrollment in Pivotal NEO100 Phase2a Trial for IDH-1 mutant Recurrent High‑Grade Glioma and Expects Interim Data Readout in SixMonths (Q22026)

November 13, 2025

From NeOnc Technologies Holdings, Inc.

Via GlobeNewswire

NeOnc Technologies Reports Updated Clinical Results

November 12, 2025

From NeOnc Technologies Holdings, Inc.

Via GlobeNewswire

NeOnc Technologies (Nasdaq: NTHI) to Host Investor Conference Call to Present Data Updates from Ongoing NEO100-1 Phase 1/2a Clinical Trial and Compassionate Use Program

November 07, 2025

From NeOnc Technologies Holdings, Inc.

Via GlobeNewswire

NeOnc Technologies Appoints Amir Heshmatpour as Chief Executive Officer to Drive Next Phase of Clinical and Corporate Growth

November 04, 2025

From NeOnc Technologies Holdings, Inc.

Via GlobeNewswire

His Highness Sheikh Nahyan bin Zayed Al Nahyan Assumes Executive Chairmanship of NeOnc Technologies' Subsidiary, NuroMENA, Pioneering UAE-US Partnership in Brain Cancer Treatment

October 28, 2025

From NeOnc Technologies Holdings, Inc.

Via GlobeNewswire

Meet the Companies - New to The Street's Accredited Investor Event Returns October 21-22 at Hudson Yards, NYC

October 10, 2025

Via ACCESS Newswire

NeOnc Technologies' Subsidiary, NuroMENA, Signs Master Services Agreement with M42’s IROS and Expands Board of Directors

October 09, 2025

From NeOnc Technologies Holdings, Inc.

Via GlobeNewswire

New to The Street to Broadcast Tonight on Fox Business 10:30 PM PST Featuring NeOnc Technologies, FLOKI, XION, Sharps Technology, and Aeries Technology

October 06, 2025

Via ACCESS Newswire

NeOnc Technologies and Quazar Investment Set to Close $50 Million Strategic Partnership by October 23rd Following Final UAE Tax Approvals

October 06, 2025

From NeOnc Technologies Holdings, Inc.

Via GlobeNewswire

NeOnc Technologies Appoints Dr. David M. Ashley, Director of The Preston Robert Tisch Brain Tumor Center at Duke, to Scientific Advisory Board

October 02, 2025

From NeOnc Technologies Holdings, Inc.

Via GlobeNewswire

NeOnc Technologies Welcomes Dr. Alexandra M. Miller, Chief of Neuro-Oncology and Co-Director of the Brain and Spine Tumor Center at NYU Langone Health’s Perlmutter Cancer Center, to Its Scientific Advisory Board

October 01, 2025

From NeOnc Technologies Holdings, Inc.

Via GlobeNewswire

NeOnc Technologies Appoints Renowned Neuro-Oncologist Dr. Henry S. Friedman to Scientific Advisory Board

September 29, 2025

From NeOnc Technologies Holdings, Inc.

Via GlobeNewswire

New to The Street to Broadcast Saturday, September 27th Featuring NeOnc Pharma $NTHI and Other Innovative Companies

September 26, 2025

Via ACCESS Newswire

NeOnc Technologies to Showcase Progress on Addressing Brain Cancer to 63 Million TV Households on “Health Uncensored with Dr. Drew” on the Lifetime Network on September 25, premiering nationwide at 8:00 a.m. ET/PT

September 22, 2025

From NeOnc Technologies Holdings, Inc.

Via GlobeNewswire

New to The Street to Broadcast Episode 686 Tonight on Bloomberg Television at 6:30 PM EST

September 13, 2025

Via ACCESS Newswire

NeOnc Technologies Receives FDA Authorization to Proceed with Phase II Clinical Trial of NEO212 – A First-in-Class Oral Chemical Conjugated Chemotherapy Candidate for Brain Cancer

September 10, 2025

From NeOnc Technologies Holdings, Inc.

Via GlobeNewswire

NeOnc Technologies Closes Strategic Acquisition of Advanced AI and 3D Bioprinting IP, Appointing World-Renowned Scientist Dr. Ishwar K. Puri to its Board

August 25, 2025

From NeOnc Technologies Holdings, Inc.

Via GlobeNewswire

NeOnc Technologies Holdings Reports Second Quarter 2025 Results and Provides Operational Update

August 19, 2025

From NeOnc Technologies Holdings, Inc.

Via GlobeNewswire

New to The Street's Esteemed Client NeOnc Technologies Finalizes $50 Million Strategic Partnership with Quazar Investment as NuroMENA Holdings Receives ADGM Incorporation

August 11, 2025

Via ACCESS Newswire

NeOnc Technologies Finalizes All Contingencies for $50 Million Strategic Partnership with Quazar Investment as NuroMENA Holdings Receives ADGM Incorporation

August 11, 2025

From NeOnc Technologies Holdings, Inc.

Via GlobeNewswire

Frequently Asked Questions

Is NeOnc Technologies Holdings, Inc. - Common Stock publicly traded?

Yes, NeOnc Technologies Holdings, Inc. - Common Stock is publicly traded.

What exchange does NeOnc Technologies Holdings, Inc. - Common Stock trade on?

NeOnc Technologies Holdings, Inc. - Common Stock trades on the Nasdaq Stock Market

What is the ticker symbol for NeOnc Technologies Holdings, Inc. - Common Stock?

The ticker symbol for NeOnc Technologies Holdings, Inc. - Common Stock is NTHI on the Nasdaq Stock Market

What is the current price of NeOnc Technologies Holdings, Inc. - Common Stock?

The current price of NeOnc Technologies Holdings, Inc. - Common Stock is 8.638

When was NeOnc Technologies Holdings, Inc. - Common Stock last traded?

The last trade of NeOnc Technologies Holdings, Inc. - Common Stock was at 01/02/26 12:55 PM ET

What is the market capitalization of NeOnc Technologies Holdings, Inc. - Common Stock?

The market capitalization of NeOnc Technologies Holdings, Inc. - Common Stock is 168.21M

How many shares of NeOnc Technologies Holdings, Inc. - Common Stock are outstanding?

NeOnc Technologies Holdings, Inc. - Common Stock has 168M shares outstanding.

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.